Certified by Founder Lodge
Novo Holdings
Denmark - Hellerup, Gentofte
INVESTOR
1 Disclosed Funding Rounds $50,000,000
128 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Novo Holdings is a holding and investment company, responsible for managing the operating and financial assets of the Novo Nordisk Foundation.
Headquartered in Copenhagen and wholly owned b
| Company | Date | Round | Raised |
|---|---|---|---|
 Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
 Hoba Therapeutics |
December, 12 ,2023 | Series A | $24,800,000 |
 Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
 AMSilk GmbH | Biotech Materials |
April, 05 ,2023 | Unknown | $27,344,000 |
 MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
 MEDGENOME |
September, 03 ,2022 | Unknown | $50,000,000 |
 Cleveland Diagnostics, Inc. |
January, 18 ,2024 | Unknown | $75,000,000 |
| Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
 Qure.ai |
March, 29 ,2022 | Series C | $40,000,000 |
| Hoba Therapeutics |
December, 12 ,2023 | Series A | $24,800,000 |
| Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
| Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
 Octave |
June, 16 ,2023 | Series C | $52,000,000 |
| MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
| AMSilk GmbH | Biotech Materials |
April, 05 ,2023 | Unknown | $27,344,000 |
| Cleveland Diagnostics, Inc. |
January, 18 ,2024 | Unknown | $75,000,000 |
 Elo Life Systems |
January, 25 ,2024 | Series A | $20,500,000 |
| Qure.ai |
March, 29 ,2022 | Series C | $40,000,000 |
| Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
| Hoba Therapeutics |
December, 12 ,2023 | Series A | $24,800,000 |
 Halodoc |
August, 02 ,2023 | Series D | $100,000,000 |
| Octave |
June, 16 ,2023 | Series C | $52,000,000 |
| Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
| AMSilk GmbH | Biotech Materials |
April, 05 ,2023 | Unknown | $27,344,000 |
 CARPL - Radiology AI Platform |
February, 02 ,2024 | Unknown | $6,000,000 |
| Elo Life Systems |
January, 25 ,2024 | Series A | $20,500,000 |
| Cleveland Diagnostics, Inc. |
January, 18 ,2024 | Unknown | $75,000,000 |
| Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
 Bactolife |
August, 14 ,2023 | Series A | $30,000,000 |
| Halodoc |
August, 02 ,2023 | Series D | $100,000,000 |
| Octave |
June, 16 ,2023 | Series C | $52,000,000 |
| Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| CARPL - Radiology AI Platform |
February, 02 ,2024 | Unknown | $6,000,000 |
| Elo Life Systems |
January, 25 ,2024 | Series A | $20,500,000 |
| Cleveland Diagnostics, Inc. |
January, 18 ,2024 | Unknown | $75,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Bactolife |
August, 14 ,2023 | Series A | $30,000,000 |
| Halodoc |
August, 02 ,2023 | Series D | $100,000,000 |
| Octave |
June, 16 ,2023 | Series C | $52,000,000 |
| MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| CARPL - Radiology AI Platform |
February, 02 ,2024 | Unknown | $6,000,000 |
| Elo Life Systems |
January, 25 ,2024 | Series A | $20,500,000 |
 Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Bactolife |
August, 14 ,2023 | Series A | $30,000,000 |
| Halodoc |
August, 02 ,2023 | Series D | $100,000,000 |
| Hoba Therapeutics |
December, 12 ,2023 | Series A | $24,800,000 |
| MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| CARPL - Radiology AI Platform |
February, 02 ,2024 | Unknown | $6,000,000 |
 F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Bactolife |
August, 14 ,2023 | Series A | $30,000,000 |
| Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
| Hoba Therapeutics |
December, 12 ,2023 | Series A | $24,800,000 |
| MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Booster Therapeutics |
October, 11 ,2024 | Seed | $15,000,000 |
| F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Cleveland Diagnostics, Inc. |
January, 18 ,2024 | Unknown | $75,000,000 |
| Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
| Hoba Therapeutics |
December, 12 ,2023 | Series A | $24,800,000 |
| MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
| Elo Life Systems |
January, 25 ,2024 | Series A | $20,500,000 |
| Booster Therapeutics |
October, 11 ,2024 | Seed | $15,000,000 |
| F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
 AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
| Cleveland Diagnostics, Inc. |
January, 18 ,2024 | Unknown | $75,000,000 |
| Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
| Hoba Therapeutics |
December, 12 ,2023 | Series A | $24,800,000 |
| CARPL - Radiology AI Platform |
February, 02 ,2024 | Unknown | $6,000,000 |
| Elo Life Systems |
January, 25 ,2024 | Series A | $20,500,000 |
| Booster Therapeutics |
October, 11 ,2024 | Seed | $15,000,000 |
| F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
 Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
| AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
| Cleveland Diagnostics, Inc. |
January, 18 ,2024 | Unknown | $75,000,000 |
| Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| CARPL - Radiology AI Platform |
February, 02 ,2024 | Unknown | $6,000,000 |
| Elo Life Systems |
January, 25 ,2024 | Series A | $20,500,000 |
| Booster Therapeutics |
October, 11 ,2024 | Seed | $15,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
| Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
| F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| Cleveland Diagnostics, Inc. |
January, 18 ,2024 | Unknown | $75,000,000 |
| CARPL - Radiology AI Platform |
February, 02 ,2024 | Unknown | $6,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Booster Therapeutics |
October, 11 ,2024 | Seed | $15,000,000 |
| Elo Life Systems |
January, 25 ,2024 | Series A | $20,500,000 |
| Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
| AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
| CARPL - Radiology AI Platform |
February, 02 ,2024 | Unknown | $6,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Booster Therapeutics |
October, 11 ,2024 | Seed | $15,000,000 |
 Coave Therapeutics |
January, 09 ,2025 | Series A | $32,000,000 |
| Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
| F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
| Booster Therapeutics |
October, 11 ,2024 | Seed | $15,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
| Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
| Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Coave Therapeutics |
January, 09 ,2025 | Series A | $32,000,000 |
| Coave Therapeutics |
January, 09 ,2025 | Series A | $32,000,000 |
 Newleos Therapeutics |
February, 20 ,2025 | Series A | $93,500,000 |
| F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| Booster Therapeutics |
October, 11 ,2024 | Seed | $15,000,000 |
| AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
| Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
| Coave Therapeutics |
January, 09 ,2025 | Series A | $32,000,000 |
| Newleos Therapeutics |
February, 20 ,2025 | Series A | $93,500,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
